Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and latest CE information More Information
This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.
Choose from the criteria below to find an activity that fits you best.
|A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC)|
NOTE: If you attended the live CE webinar titled "Adult Pneumococcal Vaccinations: The Vital Role of the Pharmacist in Improving Outcomes" that was held on October 27 and November 2, 2016, AND received CE credit (i.e. a pharmacist CE statement with ACPE Universal Activity Number 0221-9999-16-323-L01-P), you are NOT eligible to also receive CE credit for this home-study activity.
Every year in the U.S., pneumococcal disease kills thousands of adults, and many
more end up hospitalized, yet vaccination rates lag behind public health standards.
Pharmacists are in a strong position to ensure that those adults of highest need receive
timely vaccination according to the most recent national recommendations.
This activity will provide you with strategies for improving vaccination rates in eligible patients and underserved populations, as well as tactics for overcoming common barriers to improve outcomes and reduce the high burden of this disease on the health system. Expert faculty will present case scenarios.
The target audience for this activity includes pharmacists working in community, long-term care and health-system settings. At the completion of this webinar, the participant will be able to:
Paul O. Gubbins, PharmD
Associate Dean, Missouri State University
Vice Chair & Professor, Division of Pharmacy Practice & Administration
University of Missouri-Kansas City School of Pharmacy at MSU
Kansas City, Missouri
Michael E. Klepser, PharmD, FCCP
Professor of Pharmacy Practice
Ferris State University
College of Pharmacy
Big Rapids, Michigan
Release Date: 10-27-2016
Expiration Date: 12-31-2017
This activity is jointly provided by ProCE, Inc. and the Society of Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-16-323-H01-P has been assigned to this home-study knowledge-based activity (initial release date October 27, 2016). This activity is approved for 1.0 contact hours (0.1 CEUs) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and
scientific rigor in all of its continuing education activities. Faculty must disclose
to participants any significant financial interest or affiliation with companies that
manufacture or market products discussed in this activity. Dr. Gubbins has no relevant
commercial or financial relationships to disclose. Dr. Klepser has no relevant commercial
or financial relationships to disclose. A portion of grant funds received by ProCE
from Pfizer Inc. will be used to compensate the faculty for this presentation.
Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.
This activity is supported by an educational grant from Pfizer Inc.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.